Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-04-08

AUTHORS

Anna Novell, Montserrat Martínez-Alonso, Moises Mira, Jordi Tarragona, Antonieta Salud, Xavier Matias-Guiu

ABSTRACT

Locally advanced rectal cancer (LARC) is associated with a 25 % rate of metastases. The prognostic and predictive relevances of the expression of five proteins (c-FLIPL/s, HIF-1α, β-catenin, p65, and p105/p50 NF-κβ) were assessed. This is a retrospective study. From 1998 to 2009, 152 patients with stage II/III rectal cancer were treated with radio-chemotherapy. TMAs constructed with tumor and normal tissue from the diagnostic endoscopic biopsy and the surgical specimen after chemoradiotherapy were subjected to immunohistochemical (IHC) analysis. Results were correlated with clinical and pathological data, including progression-free survival (PFS). Four different IHC conditions were independent prognostic parameters for PFS: (1) cytoplasmic c-FLIPL/s (p = 0.007), (2) nuclear HIF-1α (p = 0.020), (3) a change in the cytoplasmic p65 between the diagnostic biopsy and the post-treatment specimen (p = 0.004), and (4) a change in the cytoplasmic c-FLIPL/s between the diagnostic biopsy and the post-treatment specimen (p = 0.021). Three different protein expression profiles, combining biomarkers, showed prognostic significance. IHC evaluation of these biomarkers in our three protein expression profiles may help to identify patients with worse prognosis and design more effective therapeutic strategies to personalize the treatment of rectal cancer. More... »

PAGES

645-654

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00428-014-1572-z

DOI

http://dx.doi.org/10.1007/s00428-014-1572-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015309875

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24711168


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CASP8 and FADD-Like Apoptosis Regulating Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoxia-Inducible Factor 1, alpha Subunit", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "NF-kappa B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Array Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Novell", 
        "givenName": "Anna", 
        "id": "sg:person.0666243505.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666243505.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biostatistics & Methological Support, IRBLleida, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Department of Biostatistics & Methological Support, IRBLleida, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mart\u00ednez-Alonso", 
        "givenName": "Montserrat", 
        "id": "sg:person.01356511475.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356511475.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Department of Radiation Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mira", 
        "givenName": "Moises", 
        "id": "sg:person.01234630226.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234630226.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tarragona", 
        "givenName": "Jordi", 
        "id": "sg:person.01143343305.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143343305.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain", 
            "Department of Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salud", 
        "givenName": "Antonieta", 
        "id": "sg:person.01166410030.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166410030.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matias-Guiu", 
        "givenName": "Xavier", 
        "id": "sg:person.01327473771.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327473771.68"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00428-005-1264-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029598834", 
          "https://doi.org/10.1007/s00428-005-1264-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-005-0788-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048668338", 
          "https://doi.org/10.1007/s00384-005-0788-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10585-008-9155-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009116883", 
          "https://doi.org/10.1007/s10585-008-9155-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1739", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048794721", 
          "https://doi.org/10.1038/nrc1739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-8-320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023435826", 
          "https://doi.org/10.1186/1471-2407-8-320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncb1534", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017488213", 
          "https://doi.org/10.1038/ncb1534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-003-0494-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031814956", 
          "https://doi.org/10.1007/s00384-003-0494-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s000110050358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033964531", 
          "https://doi.org/10.1007/s000110050358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028834068", 
          "https://doi.org/10.1038/nrc2902"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-04-08", 
    "datePublishedReg": "2014-04-08", 
    "description": "Locally advanced rectal cancer (LARC) is associated with a 25\u00a0% rate of metastases. The prognostic and predictive relevances of the expression of five proteins (c-FLIPL/s, HIF-1\u03b1, \u03b2-catenin, p65, and p105/p50 NF-\u03ba\u03b2) were assessed. This is a retrospective study. From 1998 to 2009, 152 patients with stage II/III rectal cancer were treated with radio-chemotherapy. TMAs constructed with tumor and normal tissue from the diagnostic endoscopic biopsy and the surgical specimen after chemoradiotherapy were subjected to immunohistochemical (IHC) analysis. Results were correlated with clinical and pathological data, including progression-free survival (PFS). Four different IHC conditions were independent prognostic parameters for PFS: (1) cytoplasmic c-FLIPL/s (p\u2009=\u20090.007), (2) nuclear HIF-1\u03b1 (p\u2009=\u20090.020), (3) a change in the cytoplasmic p65 between the diagnostic biopsy and the post-treatment specimen (p\u2009=\u20090.004), and (4) a change in the cytoplasmic c-FLIPL/s between the diagnostic biopsy and the post-treatment specimen (p\u2009=\u20090.021). Three different protein expression profiles, combining biomarkers, showed prognostic significance. IHC evaluation of these biomarkers in our three protein expression profiles may help to identify patients with worse prognosis and design more effective therapeutic strategies to personalize the treatment of rectal cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00428-014-1572-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1106235", 
        "issn": [
          "0945-6317", 
          "1432-2307"
        ], 
        "name": "Virchows Archiv", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "464"
      }
    ], 
    "keywords": [
      "progression-free survival", 
      "post-treatment specimen", 
      "rectal cancer", 
      "diagnostic biopsy", 
      "FLIPL/S", 
      "stage II/III rectal cancer", 
      "HIF-1\u03b1", 
      "diagnostic endoscopic biopsy", 
      "advanced rectal cancer", 
      "rate of metastasis", 
      "independent prognostic parameter", 
      "protein expression profiles", 
      "effective therapeutic strategy", 
      "nuclear HIF-1\u03b1", 
      "retrospective study", 
      "endoscopic biopsy", 
      "prognostic significance", 
      "worse prognosis", 
      "surgical specimen", 
      "prognostic value", 
      "NF-\u03ba\u03b2", 
      "prognostic parameters", 
      "pathological data", 
      "cytoplasmic p65", 
      "therapeutic strategies", 
      "immunohistochemical analysis", 
      "IHC evaluation", 
      "cytoplasmic c", 
      "expression profiles", 
      "stage II", 
      "cancer", 
      "normal tissues", 
      "biopsy", 
      "different protein expression profiles", 
      "patients", 
      "predictive relevance", 
      "biomarkers", 
      "chemoradiotherapy", 
      "prognosis", 
      "metastasis", 
      "tumors", 
      "p65", 
      "survival", 
      "treatment", 
      "tissue", 
      "changes", 
      "profile", 
      "expression", 
      "specimen", 
      "significance", 
      "evaluation", 
      "protein", 
      "study", 
      "rate", 
      "relevance", 
      "TMA", 
      "data", 
      "strategies", 
      "analysis", 
      "results", 
      "values", 
      "conditions", 
      "parameters", 
      "II/III rectal cancer", 
      "III rectal cancer", 
      "different IHC conditions", 
      "IHC conditions"
    ], 
    "name": "Prognostic value of c-FLIPL/s, HIF-1\u03b1, and NF-\u03ba\u03b2 in stage II and III rectal cancer", 
    "pagination": "645-654", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015309875"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00428-014-1572-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24711168"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00428-014-1572-z", 
      "https://app.dimensions.ai/details/publication/pub.1015309875"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_639.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00428-014-1572-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00428-014-1572-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00428-014-1572-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00428-014-1572-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00428-014-1572-z'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      22 PREDICATES      120 URIs      103 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00428-014-1572-z schema:about N194826a0c6a14d488c11e99b71848aed
2 N25d8c6fcf6be4aafb6fde952db017279
3 N3748d4682f454d9aa0d9b7a17e28a7e2
4 N43c2f1e3d81546f0a4c463706b5bdcd9
5 N5c3796afc13e4522a61d349824aca317
6 N739dcf39aeba4ccea442ddf5d00c1283
7 N83461e027c884ed999c41f24d847eb37
8 N9ee8b76a5c9f48338183957e62a669fb
9 Nad2c566905064c08a0e88c64885e7a37
10 Nb1ccc919bb3c4b6bbf81755ae7ebcca6
11 Nb66712d7cf72471a92f26c5de476a3b1
12 Nba090d5261bc469b8d467d8d28b37564
13 Nbb0acf16ee904596840b9c3bb641bcd6
14 Nd685c2b331204d3ebfea5cea0b27b490
15 Ndfe99d1522b54f63a6cbcdf24126beed
16 Ne0e43e14e6df4459b77ce303920c04fe
17 Ne5863cbc3e6b4e51b6bc773f9452a392
18 Nf9186f292355488e9bfa8ab6a2494d45
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author N7e6f85b4921e418dac2ca44326d0b209
22 schema:citation sg:pub.10.1007/s000110050358
23 sg:pub.10.1007/s00384-003-0494-z
24 sg:pub.10.1007/s00384-005-0788-4
25 sg:pub.10.1007/s00428-005-1264-9
26 sg:pub.10.1007/s10585-008-9155-5
27 sg:pub.10.1038/ncb1534
28 sg:pub.10.1038/nrc1739
29 sg:pub.10.1038/nrc2902
30 sg:pub.10.1186/1471-2407-8-320
31 schema:datePublished 2014-04-08
32 schema:datePublishedReg 2014-04-08
33 schema:description Locally advanced rectal cancer (LARC) is associated with a 25 % rate of metastases. The prognostic and predictive relevances of the expression of five proteins (c-FLIPL/s, HIF-1α, β-catenin, p65, and p105/p50 NF-κβ) were assessed. This is a retrospective study. From 1998 to 2009, 152 patients with stage II/III rectal cancer were treated with radio-chemotherapy. TMAs constructed with tumor and normal tissue from the diagnostic endoscopic biopsy and the surgical specimen after chemoradiotherapy were subjected to immunohistochemical (IHC) analysis. Results were correlated with clinical and pathological data, including progression-free survival (PFS). Four different IHC conditions were independent prognostic parameters for PFS: (1) cytoplasmic c-FLIPL/s (p = 0.007), (2) nuclear HIF-1α (p = 0.020), (3) a change in the cytoplasmic p65 between the diagnostic biopsy and the post-treatment specimen (p = 0.004), and (4) a change in the cytoplasmic c-FLIPL/s between the diagnostic biopsy and the post-treatment specimen (p = 0.021). Three different protein expression profiles, combining biomarkers, showed prognostic significance. IHC evaluation of these biomarkers in our three protein expression profiles may help to identify patients with worse prognosis and design more effective therapeutic strategies to personalize the treatment of rectal cancer.
34 schema:genre article
35 schema:inLanguage en
36 schema:isAccessibleForFree false
37 schema:isPartOf N7a9d480d7d3145ad977929a4e3e34509
38 Ndd9e88d893b24bb6952a3dfc78b9510d
39 sg:journal.1106235
40 schema:keywords FLIPL/S
41 HIF-1α
42 IHC conditions
43 IHC evaluation
44 II/III rectal cancer
45 III rectal cancer
46 NF-κβ
47 TMA
48 advanced rectal cancer
49 analysis
50 biomarkers
51 biopsy
52 cancer
53 changes
54 chemoradiotherapy
55 conditions
56 cytoplasmic c
57 cytoplasmic p65
58 data
59 diagnostic biopsy
60 diagnostic endoscopic biopsy
61 different IHC conditions
62 different protein expression profiles
63 effective therapeutic strategy
64 endoscopic biopsy
65 evaluation
66 expression
67 expression profiles
68 immunohistochemical analysis
69 independent prognostic parameter
70 metastasis
71 normal tissues
72 nuclear HIF-1α
73 p65
74 parameters
75 pathological data
76 patients
77 post-treatment specimen
78 predictive relevance
79 profile
80 prognosis
81 prognostic parameters
82 prognostic significance
83 prognostic value
84 progression-free survival
85 protein
86 protein expression profiles
87 rate
88 rate of metastasis
89 rectal cancer
90 relevance
91 results
92 retrospective study
93 significance
94 specimen
95 stage II
96 stage II/III rectal cancer
97 strategies
98 study
99 surgical specimen
100 survival
101 therapeutic strategies
102 tissue
103 treatment
104 tumors
105 values
106 worse prognosis
107 schema:name Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer
108 schema:pagination 645-654
109 schema:productId N0a193dc80b9b4eb19c0971124ac701fb
110 N9c7043a3b0b14709ad52195d97bd4645
111 Ne0a455de19d24ad98f80b27f7dfd9821
112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015309875
113 https://doi.org/10.1007/s00428-014-1572-z
114 schema:sdDatePublished 2022-01-01T18:34
115 schema:sdLicense https://scigraph.springernature.com/explorer/license/
116 schema:sdPublisher N0a4606abf71147b1a884a99e8381c89a
117 schema:url https://doi.org/10.1007/s00428-014-1572-z
118 sgo:license sg:explorer/license/
119 sgo:sdDataset articles
120 rdf:type schema:ScholarlyArticle
121 N0a193dc80b9b4eb19c0971124ac701fb schema:name pubmed_id
122 schema:value 24711168
123 rdf:type schema:PropertyValue
124 N0a4606abf71147b1a884a99e8381c89a schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N194826a0c6a14d488c11e99b71848aed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Proportional Hazards Models
128 rdf:type schema:DefinedTerm
129 N1d2fdc2455904826b2650dd5bf5a8c65 rdf:first sg:person.01166410030.85
130 rdf:rest N6e990e0163f04e1a933b4e9bda2d1fc2
131 N25d8c6fcf6be4aafb6fde952db017279 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Biomarkers, Tumor
133 rdf:type schema:DefinedTerm
134 N3748d4682f454d9aa0d9b7a17e28a7e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Retrospective Studies
136 rdf:type schema:DefinedTerm
137 N43c2f1e3d81546f0a4c463706b5bdcd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Middle Aged
139 rdf:type schema:DefinedTerm
140 N5c3796afc13e4522a61d349824aca317 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Prognosis
142 rdf:type schema:DefinedTerm
143 N6e990e0163f04e1a933b4e9bda2d1fc2 rdf:first sg:person.01327473771.68
144 rdf:rest rdf:nil
145 N739dcf39aeba4ccea442ddf5d00c1283 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Hypoxia-Inducible Factor 1, alpha Subunit
147 rdf:type schema:DefinedTerm
148 N7736d160f1fa44f6bbe42f8461fa5abf rdf:first sg:person.01356511475.14
149 rdf:rest Nc2f30c8f7b4e463c8f7d53f4c442fe62
150 N7a9d480d7d3145ad977929a4e3e34509 schema:volumeNumber 464
151 rdf:type schema:PublicationVolume
152 N7e6f85b4921e418dac2ca44326d0b209 rdf:first sg:person.0666243505.60
153 rdf:rest N7736d160f1fa44f6bbe42f8461fa5abf
154 N83461e027c884ed999c41f24d847eb37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Immunohistochemistry
156 rdf:type schema:DefinedTerm
157 N9c7043a3b0b14709ad52195d97bd4645 schema:name dimensions_id
158 schema:value pub.1015309875
159 rdf:type schema:PropertyValue
160 N9ee8b76a5c9f48338183957e62a669fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name NF-kappa B
162 rdf:type schema:DefinedTerm
163 Na38f1aa953a84ca5a594e0797d7205cd rdf:first sg:person.01143343305.39
164 rdf:rest N1d2fdc2455904826b2650dd5bf5a8c65
165 Nad2c566905064c08a0e88c64885e7a37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Rectal Neoplasms
167 rdf:type schema:DefinedTerm
168 Nb1ccc919bb3c4b6bbf81755ae7ebcca6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Humans
170 rdf:type schema:DefinedTerm
171 Nb66712d7cf72471a92f26c5de476a3b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Female
173 rdf:type schema:DefinedTerm
174 Nba090d5261bc469b8d467d8d28b37564 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Aged
176 rdf:type schema:DefinedTerm
177 Nbb0acf16ee904596840b9c3bb641bcd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Male
179 rdf:type schema:DefinedTerm
180 Nc2f30c8f7b4e463c8f7d53f4c442fe62 rdf:first sg:person.01234630226.78
181 rdf:rest Na38f1aa953a84ca5a594e0797d7205cd
182 Nd685c2b331204d3ebfea5cea0b27b490 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Tissue Array Analysis
184 rdf:type schema:DefinedTerm
185 Ndd9e88d893b24bb6952a3dfc78b9510d schema:issueNumber 6
186 rdf:type schema:PublicationIssue
187 Ndfe99d1522b54f63a6cbcdf24126beed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name CASP8 and FADD-Like Apoptosis Regulating Protein
189 rdf:type schema:DefinedTerm
190 Ne0a455de19d24ad98f80b27f7dfd9821 schema:name doi
191 schema:value 10.1007/s00428-014-1572-z
192 rdf:type schema:PropertyValue
193 Ne0e43e14e6df4459b77ce303920c04fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Neoplasm Staging
195 rdf:type schema:DefinedTerm
196 Ne5863cbc3e6b4e51b6bc773f9452a392 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Kaplan-Meier Estimate
198 rdf:type schema:DefinedTerm
199 Nf9186f292355488e9bfa8ab6a2494d45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Disease-Free Survival
201 rdf:type schema:DefinedTerm
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
206 schema:name Oncology and Carcinogenesis
207 rdf:type schema:DefinedTerm
208 sg:journal.1106235 schema:issn 0945-6317
209 1432-2307
210 schema:name Virchows Archiv
211 schema:publisher Springer Nature
212 rdf:type schema:Periodical
213 sg:person.01143343305.39 schema:affiliation grid-institutes:grid.420395.9
214 schema:familyName Tarragona
215 schema:givenName Jordi
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143343305.39
217 rdf:type schema:Person
218 sg:person.01166410030.85 schema:affiliation grid-institutes:grid.420395.9
219 schema:familyName Salud
220 schema:givenName Antonieta
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166410030.85
222 rdf:type schema:Person
223 sg:person.01234630226.78 schema:affiliation grid-institutes:grid.420395.9
224 schema:familyName Mira
225 schema:givenName Moises
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234630226.78
227 rdf:type schema:Person
228 sg:person.01327473771.68 schema:affiliation grid-institutes:grid.420395.9
229 schema:familyName Matias-Guiu
230 schema:givenName Xavier
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327473771.68
232 rdf:type schema:Person
233 sg:person.01356511475.14 schema:affiliation grid-institutes:grid.420395.9
234 schema:familyName Martínez-Alonso
235 schema:givenName Montserrat
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356511475.14
237 rdf:type schema:Person
238 sg:person.0666243505.60 schema:affiliation grid-institutes:grid.420395.9
239 schema:familyName Novell
240 schema:givenName Anna
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666243505.60
242 rdf:type schema:Person
243 sg:pub.10.1007/s000110050358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033964531
244 https://doi.org/10.1007/s000110050358
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s00384-003-0494-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1031814956
247 https://doi.org/10.1007/s00384-003-0494-z
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s00384-005-0788-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048668338
250 https://doi.org/10.1007/s00384-005-0788-4
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s00428-005-1264-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029598834
253 https://doi.org/10.1007/s00428-005-1264-9
254 rdf:type schema:CreativeWork
255 sg:pub.10.1007/s10585-008-9155-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009116883
256 https://doi.org/10.1007/s10585-008-9155-5
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/ncb1534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017488213
259 https://doi.org/10.1038/ncb1534
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/nrc1739 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048794721
262 https://doi.org/10.1038/nrc1739
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/nrc2902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028834068
265 https://doi.org/10.1038/nrc2902
266 rdf:type schema:CreativeWork
267 sg:pub.10.1186/1471-2407-8-320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023435826
268 https://doi.org/10.1186/1471-2407-8-320
269 rdf:type schema:CreativeWork
270 grid-institutes:grid.420395.9 schema:alternateName Department of Biostatistics & Methological Support, IRBLleida, Lleida, Spain
271 Department of Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain
272 Department of Radiation Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain
273 Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain
274 schema:name Department of Biostatistics & Methological Support, IRBLleida, Lleida, Spain
275 Department of Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain
276 Department of Radiation Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Lleida, Spain
277 Departments of Pathology and Medical Oncology, Hospital Universitari Arnau de Vilanova. Universitat de Lleida, IRBLleida, Av. Rovira Roure, 80, 25198, Lleida, Spain
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...